Alpha 2.0
Login Register
» Authors » Kimberle Chapin

Kimberle Chapin

Explore the profile of Kimberle Chapin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 397
Followers 0
Related Specialties
General Medicine
Microbiology
Infectious Diseases
Top 10 Co-Authors
Sarah Andrea
Ian C Michelow
Zaid Alhinai
Leonard A Mermel
Nicole Alexander-Scott
Aris C Garro
Russell J McCulloh
Gregory Lockhart
Kari Simonsen
Michael Koster
Published In
J Clin Microbiol
Expert Rev Mol Diagn
Med Health R I
R I Med J (2013)
Clin Chem
Affiliations
Soon will be listed here.
Recent Articles
11.
Risk factors for prolonged H1N1 influenza among hospitalized patients
Pop-Vicas A, Chahin A, Hagau D, Chapin K
Am J Infect Control . 2013 Aug; 41(12):1284-6. PMID: 23899819
In our study, 50% of 42 hospitalized patients with 2009 H1N1 pandemic influenza experienced symptoms longer than 1 week. Older age and delay in oseltamivir initiation were associated with prolonged...
12.
Reducing Clostridium difficile incidence, colectomies, and mortality in the hospital setting: a successful multidisciplinary approach
Mermel L, Jefferson J, Blanchard K, Parenteau S, Mathis B, Chapin K, et al.
Jt Comm J Qual Patient Saf . 2013 Jul; 39(7):298-305. PMID: 23888639
Background: Health care associated Clostridium difficile infections are a major cause of morbidity and mortality in hospitals. In the United States, from 2000 through 2009, discharge diagnoses from hospitals in...
13.
Respiratory viral testing: new frontiers in diagnostics and implications for antimicrobial stewardship
McCulloh R, Koster M, Chapin K
Virulence . 2013 Jan; 4(1):1-2. PMID: 23314568
No abstract available.
14.
Recommendations for the diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis, including extra-genital sites
Chan P, Janvier M, Alexander N, Kojic E, Chapin K
Med Health R I . 2012 Sep; 95(8):252-4. PMID: 22970467
No abstract available.
15.
Discrepancies in testing recommendations for Clostridium difficile infection: updated review favors amplification test systems
Chapin K
Expert Rev Mol Diagn . 2012 Apr; 12(3):223-6. PMID: 22468811
No abstract available.
16.
Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel
Miller J, Astles R, Baszler T, Chapin K, Carey R, Garcia L, et al.
MMWR Suppl . 2012 Jan; 61(1):1-102. PMID: 22217667
Prevention of injuries and occupational infections in U.S. laboratories has been a concern for many years. CDC and the National Institutes of Health addressed the topic in their publication Biosafety...
17.
Multiplex PCR for detection of respiratory viruses: can the laboratory performing a respiratory viral panel (RVP) assay trigger better patient care and clinical outcomes?
Chapin K
Clin Biochem . 2011 Nov; 44(7):496-497. PMID: 22036344
No abstract available.
18.
Prevalence of Lyme meningitis in children with aseptic meningitis in a Lyme disease-endemic region
Garro A, Rutman M, Simonsen K, Jaeger J, Chapin K, Lockhart G
Pediatr Infect Dis J . 2011 Sep; 30(11):990-2. PMID: 21909050
This study determined the prevalence of Lyme meningitis in children with undifferentiated aseptic meningitis from April to December in a Lyme disease-endemic region. Of the 60 children, 8 were seropositive...
19.
APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens
Chapin K, Andrea S
Expert Rev Mol Diagn . 2011 Sep; 11(7):679-88. PMID: 21902528
The APTIMA(®) Trichomonas vaginalis (APTIMA TV; Gen-Probe Inc.) assay is the only amplification-based assay for T. vaginalis (TV) currently cleared by the US FDA. The assay was cleared in April...
20.
Community and nursing home residents with carbapenemase-producing Klebsiella pneumoniae infection
Mills J, Chapin K, Andrea S, Furtado G, Mermel L
Infect Control Hosp Epidemiol . 2011 May; 32(6):629-31. PMID: 21558781
No abstract available.